[go: up one dir, main page]

PT968174E - 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico - Google Patents

2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico

Info

Publication number
PT968174E
PT968174E PT98902173T PT98902173T PT968174E PT 968174 E PT968174 E PT 968174E PT 98902173 T PT98902173 T PT 98902173T PT 98902173 T PT98902173 T PT 98902173T PT 968174 E PT968174 E PT 968174E
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
aminotetralin
septic shock
Prior art date
Application number
PT98902173T
Other languages
English (en)
Inventor
Piero Foresta
Gian Piero Moretti
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT968174E publication Critical patent/PT968174E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT98902173T 1997-02-03 1998-01-28 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico PT968174E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive

Publications (1)

Publication Number Publication Date
PT968174E true PT968174E (pt) 2003-06-30

Family

ID=11404706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98902173T PT968174E (pt) 1997-02-03 1998-01-28 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico

Country Status (10)

Country Link
US (1) US6225501B1 (pt)
EP (1) EP0968174B1 (pt)
JP (1) JP2001509802A (pt)
AT (1) ATE231486T1 (pt)
DE (1) DE69810906T2 (pt)
DK (1) DK0968174T3 (pt)
ES (1) ES2190581T3 (pt)
IT (1) IT1290910B1 (pt)
PT (1) PT968174E (pt)
WO (1) WO1998033762A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
IT1317050B1 (it) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv.
CN103360360A (zh) * 2012-04-10 2013-10-23 肖竹平 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法
CA3076823A1 (en) 2017-10-05 2019-04-11 Biogen Inc. Process for preparing alpha-carboxamide pyrrolidine derivatives
CA3136426A1 (en) * 2019-04-10 2020-10-15 Biogen Inc. Processes for preparing alpha-carboxamide pyrrolidine derivatives
CN115724758B (zh) * 2021-08-24 2024-12-27 杭州中美华东制药有限公司 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
US6225501B1 (en) 2001-05-01
EP0968174B1 (en) 2003-01-22
WO1998033762A1 (en) 1998-08-06
ITRM970050A1 (it) 1998-08-03
DE69810906D1 (de) 2003-02-27
IT1290910B1 (it) 1998-12-14
DE69810906T2 (de) 2003-11-13
DK0968174T3 (da) 2003-05-12
JP2001509802A (ja) 2001-07-24
HK1025558A1 (en) 2000-11-17
ATE231486T1 (de) 2003-02-15
ES2190581T3 (es) 2003-08-01
EP0968174A1 (en) 2000-01-05

Similar Documents

Publication Publication Date Title
BR9913752B1 (pt) uso de um produto para proteÇço de tecidos, e, processo para tratamento de tecidos.
BR0015110A (pt) Métodos de tratamento de doenças de proliferação celular, de tratamento de um distúrbio associado com a atividade da cinesina ksp, de inibição da cinesina ksp, de triagem de moduladores da cinesina kps e de triagem de compostos que se ligam na cinesina ksp, e, compostos
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
BR9608405A (pt) Composto composi-Æo farmaceutica e processo para tratar um paciente que sofre de um distÚrbio fisiolÄgico
BRPI0111116B8 (pt) imitadores de trombopoietina
BR9401828A (pt) Derivados oticamente ativos de 2-imidazolin-5-onas ou de 2-imidazolin-5-tionas, processo para sua preparação, compostos intermediáros oticamente ativos, composições fungicidas e processo de tratamento de culturas
DE60010456D1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
BR9812837A (pt) Processo para fazer um composto, e, composto
SE9704546D0 (sv) Novel compounds
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
BR9707489A (pt) Composto composição farmacêutica e processo para tratar um paciente sofrendo de um distúrbio fisilógico
BR9607346A (pt) Composto utilizaç o de um composto composiç o farmacéutica e processo para o tratamento de um mamifero e para e preparaç o de compostos
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
DE69034070D1 (de) Racemisches Huperzin A
BR9808923A (pt) Composto, e, processo para fazer o mesmo
PT968174E (pt) 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico
BR9602337A (pt) Composto processo para sua preparação usos do mesmo processo para tratamento de arritmias e medicamento
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
PT866699E (pt) Utilizacao de inibidores de colinesterase para o fabrico de um medicamento para o tratamento de xerostomia
NZ328198A (en) a pharmaceutical composition containing hydroxyzine and a serotonin uptake inhibitor
BR9100431A (pt) Derivados de halogenoalilazolila,processo para sua fabricacao,aplicacao destes derivados,agente microbicida,processo para combater microorganismos,processo para a fabricacao de agentes microbicidas
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis